We previously reported the therapeutic efficacy of adenoviral transfer of VASH1 in diabetic mice models [12, 13], and exacerbation of diabetic renal alterations in VASH1 heterozygous deficient mice [14], indicating the protective role of VASH1 in diabetic nephropathy. This evidence concerns the gene VASH1 and diabetic kidney disease.